Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats

Abstract Background Parasitic bronchopneumonia in domestic cats in Europe, which can manifest with moderate to severe clinical signs, is frequently caused by Troglostrongylus brevior. Data on epizootiological and clinical relevance of cat troglostrongylosis have been published in the last decade but...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Donato Traversa, Katharina Raue, Hannah Ringeisen, Katrin Blazejak, Katrin Bisterfeld, Angela Di Cesare, Mariasole Colombo, Claudia Böhm, Christina Strube, Matthias Pollmeier
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-02-01
coleção:	Parasites & Vectors
Assuntos:	Cat Moxidectin Treatment Feline lungworms Troglostrongylus brevior
Acesso em linha:	https://doi.org/10.1186/s13071-022-05185-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!